Jim Joyce is the Co-Founder, Chairman, and CEO of Sigyn Therapeutics, and we talk about removing inflammatory targets from the bloodstream with advanced blood purification technology. Jim says, “The next transformative step in the recipe of blood purification is the advancement of devices that can address the sources of inflammation, which could be a viral or […]

COVID-19-Related Mesoblast Limited presented 90-day survival outcomes from the 222-patient trial of remestemcel-L in ventilator-dependent COVID-19 patients with moderate/severe acute respiratory distress syndrome (ARDS). The data demonstrated that two doses of the drug at days 3-5 provided durable survival benefit through at least 90 days in the subgroup of patients under 65 years of age. RedHill Biopharma announced that […]

Earlier this year, the Federal Trade Commission’s (FTC) posed a roadblock in the path of sequencing giant Illumina’s $7.1 billion proposed acquisition of Grail, a healthcare company focusing on early cancer detection, and importantly, a 2016 spin-out from the former. Right now, the European Commission (EC) is also investigating the soundness of this deal. The justification provided by […]